capecitabine has been researched along with Cancer of Skin in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (27.50) | 29.6817 |
2010's | 27 (67.50) | 24.3611 |
2020's | 2 (5.00) | 2.80 |
Authors | Studies |
---|---|
Antoñanzas-Pérez, J; Cuns, CA; Estenaga, A; García-Martínez, FJ; Morelló-Vicente, A; Oteiza-Rius, I; Sanchez-Lorenzo, L; Wells, J | 1 |
García-Lozano, JA; González-Ramírez, RA; Ocampo-Candiani, J | 1 |
Ghilardi, M | 2 |
Kim, J; Nijhawan, RI; Schauder, DM | 1 |
Andrés-Lencina, JJ; Aragón-Miguel, R; Calleja-Algarra, A; Maroñas Jiménez, L; Monsálvez Honrubia, V; Ortiz Romero, PL; Prieto Barrios, M; Velasco-Tamariz, V | 1 |
Arron, ST; Asgari, MM; Blomberg, M; Demehri, S; Green, A; Harwood, C; He, SY | 1 |
Que, SKT; Schmults, CD; Zwald, FO | 1 |
Agrawal, RK; Iyer, AK; Jain, S; Kashaw, SK; Kushwah, V; Sahu, P; Sau, S | 1 |
Konda, S; O'Bryan, KW; Patel, VA; Ratner, D | 1 |
Cooper, A; Grey, A; Grimison, P; McNeil, C; O'Toole, S; Thompson, J | 1 |
Brewer, JD; Markovic, SN; Parikh, SA | 1 |
Dranitsaris, G; Lacouture, ME | 1 |
Dessart, P; Le Dû, K; Lemaire, P; Maillard, H; Prophette, B; Sandrini, J | 1 |
Glenn, CJ; Mitchell, C; Parlette, EC | 1 |
Cherpelis, B; Rudnick, EW; Thareja, S | 1 |
Ha, JY; Hwang, IG; Jung, MK; Kim, JT; Oh, EH; Park, SE | 1 |
Ishii, T; Katayama, T; Kawasaki, Y; Okubo, Y; Otsuru, M; Senba, S; Shinozaki, K; Tono, T; Yasuda, S | 1 |
Amorós, A; Casinello, J; Heredia, M; Lázaro, A; López-Alfonso, A | 1 |
Endrizzi, BT; Lee, PK | 1 |
Aneiros-Cachaza, J; Aneiros-Fernandez, J; Arias-Santiago, S; Escobar Gómez-Villalva, F; Husein-ElAhmed, H; Nicolae, A; O'Valle Ravassa, F | 1 |
Abe, H; Cho, H; Kawai, Y; Kubota, Y; Kurumi, Y; Mori, T; Shimizu, T; Tanaka, M; Tani, T; Umeda, T | 1 |
Aneiros-Fernandez, J; Arias-Santiago, S; Husein-ElAhmed, H; Naranjo-Sintes, R | 1 |
Black, JM; Boh, EE; Farris, PK; Hodari, KT; Lewis, AT; Rogers, N | 1 |
Beach, DF; Somer, R | 1 |
Brown, M; O'Reilly Zwald, F | 1 |
Aiba, S; Fujimura, T; Haga, T; Hashimoto, A; Hidaka, T; Mizuashi, M; Onami, K; Watabe, A | 1 |
Bollet, MA; Fourchotte, V; Jacob, J; Kirova, YM; Pierga, JY | 1 |
Barrick, B; Fraga, G; Matthys, B | 1 |
Schmutz, JL; Trechot, P | 1 |
Ahmed, RL; Dudek, A; Endrizzi, B; Lee, P; Ray, T | 1 |
Bogenrieder, T; Landthaler, M; Schölmerich, J; Stolz, W; Weitzel, C | 1 |
Brunner, M; Eichler, HG; Locker, G; Mader, RM; Mueller, M; Rizovski, B; Schrolnberger, C; Steger, GG; Wenzel, C | 1 |
Herrmann, R; Niemann, B; Pless, M; Rochlitz, C | 1 |
Hansel, G; Koch, A; Köstler, E; Wollina, U | 1 |
Hironou, M; Ikeda, M; Kurebayashi, J; Nakashima, K; Nomura, T; Ookubo, S; Seki, M; Shiiki, S; Sonoo, H; Tanaka, K; Udagawa, K; Yamamoto, Y | 1 |
DiLeonardo, M; Gibbons, G; Resnik, KS | 1 |
Chang, HM; Jung, JY; Kang, YK; Kim, TW; Koo, DH; Lee, JL; Lee, JS; Ryu, MH; Song, JH; Song, JS; Yook, JH | 1 |
Murakami, S; Yamamoto, Y | 1 |
Ballabeni, P; Hess, D; Koberle, D; Mattmann, S; Pagani, O; Rauch, D; Ribi, K; Rochlitz, C; Schonenberger, A; Schuller, JC; Thurlimann, B | 1 |
6 review(s) available for capecitabine and Cancer of Skin
Article | Year |
---|---|
Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
Topics: Breast Neoplasms; Capecitabine; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Clinical Decision-Making; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Incidence; Keratosis, Actinic; Off-Label Use; Organ Transplantation; Patient Selection; Risk Assessment; Risk Factors; Skin Neoplasms; Transplant Recipients | 2020 |
Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Health Behavior; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Keratoacanthoma; Neoplasm Metastasis; Niacinamide; Organ Transplantation; Papillomavirus Infections; Papillomavirus Vaccines; Photosensitivity Disorders; Quality of Life; Radiotherapy, Adjuvant; Retinoids; Skin Neoplasms; Sunlight; Transplant Recipients; Vitamin B Complex | 2017 |
Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Capecitabine; Carcinoma, Squamous Cell; Chemoprevention; Chemotherapy, Adjuvant; ErbB Receptors; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymph Nodes; Lymphatic Metastasis; Molecular Targeted Therapy; Neoplasm Staging; Neoplasms, Multiple Primary; Organ Transplantation; Programmed Cell Death 1 Receptor; Radiotherapy, Adjuvant; Sirolimus; Skin Neoplasms | 2018 |
[T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Chromosome Deletion; Combined Modality Therapy; Delayed Diagnosis; Diagnostic Errors; Fatal Outcome; Humans; Immunophenotyping; Leukemia, Prolymphocytic, T-Cell; Male; Neoplasms, Second Primary; Pentostatin; Rectal Neoplasms; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes | 2014 |
Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies.
Topics: Administration, Oral; Anilides; Antineoplastic Agents; Biphenyl Compounds; Capecitabine; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; ErbB Receptors; Erlotinib Hydrochloride; Fluorouracil; Gefitinib; Hedgehog Proteins; Molecular Targeted Therapy; Phthalazines; Podophyllotoxin; Pyridines; Quinazolines; Receptor, IGF Type 1; Retinoids; Skin Neoplasms; Tumor Burden | 2016 |
Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients.
Topics: Capecitabine; Carcinoma, Squamous Cell; Combined Modality Therapy; Deoxycytidine; Dermatologic Agents; Education, Medical, Continuing; ErbB Receptors; Female; Fluorouracil; Humans; Immunocompromised Host; Male; Organ Transplantation; Patient Education as Topic; Photochemotherapy; Prognosis; Retinoids; Risk Assessment; Skin Neoplasms; Survival Rate; Treatment Outcome | 2011 |
2 trial(s) available for capecitabine and Cancer of Skin
Article | Year |
---|---|
Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Diarrhea; Exanthema; Female; Fluorouracil; Humans; Lapatinib; Middle Aged; Models, Biological; Quinazolines; Risk Factors; ROC Curve; Skin Neoplasms | 2014 |
Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Capecitabine; Cohort Studies; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Maximum Tolerated Dose; Skin Neoplasms; Treatment Outcome; Vinblastine; Vinorelbine | 2007 |
32 other study(ies) available for capecitabine and Cancer of Skin
Article | Year |
---|---|
Response of folliculotropic mycosis fungoides to capecitabine.
Topics: Capecitabine; Humans; Mycosis Fungoides; Skin Neoplasms | 2023 |
Eruptive palmoplantar lesions induced by capecitabine: report of a case evaluated with dermoscopy.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Dermoscopy; Diagnosis, Differential; Drug Eruptions; Female; Foot Dermatoses; Hand Dermatoses; Humans; Melanoma; Middle Aged; Neoplasms, Second Primary; Skin Neoplasms | 2019 |
[A patient with subcutaneous, lymph node and bone lesions for breast cancer: a progressive response to metronomic oral vinorelbine and capecitabine.]
Topics: Administration, Metronomic; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Breast Neoplasms; Capecitabine; Female; Humans; Lymphatic Metastasis; Skin Neoplasms; Treatment Outcome; Vinorelbine | 2019 |
[A patient with subcutaneous, lymph node and bone lesions for breast cancer: a progressive response to metronomic oral vinorelbine and capecitabine.]
Topics: Administration, Metronomic; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Capecitabine; Female; Humans; Lymphatic Metastasis; Skin Neoplasms; Treatment Outcome; Vinorelbine | 2019 |
Eruptive nevi in a patient with metastatic breast cancer.
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Drug Eruptions; Female; Foot Diseases; Hand; Humans; Middle Aged; Nevus, Pigmented; Skin Neoplasms | 2017 |
pH triggered and charge attracted nanogel for simultaneous evaluation of penetration and toxicity against skin cancer: In-vitro and ex-vivo study.
Topics: Antineoplastic Agents; Apoptosis; Capecitabine; Cell Line; Chitosan; Diffusion; Drug Carriers; Drug Liberation; Ethylene Glycols; Gels; Humans; Hydrogen-Ion Concentration; Nanostructures; Particle Size; Permeability; Poloxamer; Skin; Skin Neoplasms; Surface Properties | 2019 |
Fibrohistiocytic tumors in a lung transplant patient taking oral capecitabine for nonmelanoma skin cancer chemoprevention.
Topics: Acitretin; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Deoxycytidine; Fatal Outcome; Fluorouracil; Graft vs Host Disease; Head and Neck Neoplasms; Histiocytoma, Malignant Fibrous; Humans; Keratolytic Agents; Lung Transplantation; Male; Skin Neoplasms | 2014 |
Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Capecitabine; Chemoradiotherapy; Deoxycytidine; Disease Progression; Fatal Outcome; Fluorouracil; Genes, ras; Humans; Indoles; Male; Melanoma; Mutation; Neoplasms, Second Primary; Pancreatic Neoplasms; Positron-Emission Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); ras Proteins; Skin Neoplasms; Sulfonamides; Vemurafenib | 2014 |
Oral capecitabine to prevent recurrent cutaneous squamous cell carcinoma in a lung transplant recipient.
Topics: Administration, Oral; Adult; Capecitabine; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Graft Rejection; Humans; Idiopathic Pulmonary Fibrosis; Living Donors; Lung Transplantation; Reoperation; Skin Neoplasms; Transplantation Immunology; Treatment Outcome | 2015 |
Fractionated CO₂Laser-Assisted Delivery of Topical 5-Fluorouracil as a Useful Modality for Treating Field Cutaneous Squamous Cell Carcinomas.
Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorouracil; Humans; Lasers, Gas; Male; Middle Aged; Permeability; Skin Neoplasms | 2015 |
Choroidal and skin metastases from colorectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Biopsy; Capecitabine; Choroid Neoplasms; Colorectal Neoplasms; Disease Progression; Drug Administration Schedule; Fatal Outcome; Female; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Scalp; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2016 |
[Gastric Cancer Diagnosed with Metastasis of the Navel(Sister Mary Joseph's Nodule) - A Case Report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Female; Gastrectomy; Humans; Sister Mary Joseph's Nodule; Skin Neoplasms; Stomach Neoplasms; Trastuzumab | 2016 |
Bilateral inflammatory metachronic ERBB2 (HER2/neu)-positive breast carcinoma: prolonged survival with combined chemotherapy and trastuzumab.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Cisplatin; Deoxycytidine; Female; Fluorouracil; Humans; Mastectomy; Neoplasms, Second Primary; Paclitaxel; Receptor, ErbB-2; Remission Induction; Skin Neoplasms; Survival Rate; Trastuzumab | 2008 |
Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Immunosuppressive Agents; Male; Middle Aged; Organ Transplantation; Precancerous Conditions; Skin Neoplasms | 2009 |
Cutaneous metastasis as first clinical manifestation of signet ring cell gastric carcinoma.
Topics: Aged; Antineoplastic Agents; Capecitabine; Carcinoma, Signet Ring Cell; Deoxycytidine; Docetaxel; Fluorouracil; Humans; Male; Skin Neoplasms; Stomach Neoplasms; Taxoids | 2010 |
[An effective case of liver metastasis of breast cancer treated with capecitabine + docetaxel combination therapy using vitamin B6].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Capecitabine; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Skin Neoplasms; Taxoids; Tomography, X-Ray Computed; Vitamin B 6 | 2010 |
Sister Mary Joseph's nodule as a metastasis of ovarian adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Capecitabine; Carboplatin; Colonoscopy; Deoxycytidine; Female; Fluorouracil; Humans; Liver Neoplasms; Neprilysin; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Receptors, Estrogen; Receptors, Progesterone; Sister Mary Joseph's Nodule; Skin Neoplasms; Treatment Outcome; Umbilicus; Vimentin; WT1 Proteins | 2010 |
Exudative, nonhealing scalp: a complication of systemic chemotherapy with capecitabine and bevacizumab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Eruptions; Fluorouracil; Humans; Male; Melanoma; Scalp Dermatoses; Severity of Illness Index; Skin Neoplasms | 2011 |
Novel approach to Gorlin syndrome: a patient treated with oral capecitabine.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Basal Cell Nevus Syndrome; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Male; Middle Aged; Quality of Life; Skin Neoplasms | 2011 |
Successful treatment of HER-2-positive metastatic apocrine carcinoma of the skin with lapatinib and capecitabine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Capecitabine; Carcinoma; Deoxycytidine; Fluorouracil; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lapatinib; Liver Neoplasms; Male; Middle Aged; Quinazolines; Receptor, ErbB-2; Scalp; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
[A case of cutaneous mammary re-irradiation].
Topics: Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Chemoradiotherapy; Combined Modality Therapy; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Lymphatic Irradiation; Mastectomy, Segmental; Neoplasm Recurrence, Local; Skin Neoplasms | 2012 |
Ulcerated plaques in the pelvic region of an adult female.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Deoxycytidine; Female; Fluorouracil; Genital Neoplasms, Female; Humans; Lapatinib; Middle Aged; Neoplasm Invasiveness; Quinazolines; Skin Neoplasms; Skin Ulcer | 2012 |
[Resolution of actinic keratosis with capecetabin].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Keratosis, Actinic; Male; Neoplasms, Radiation-Induced; Precancerous Conditions; Skin Neoplasms | 2012 |
Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients.
Topics: Administration, Oral; Adolescent; Adult; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Basal Cell; Child; Child, Preschool; Deoxycytidine; Female; Fluorouracil; Humans; Immunosuppressive Agents; Male; Neoplasms, Squamous Cell; Organ Transplantation; Skin Neoplasms; Tumor Burden; Young Adult | 2013 |
Eruptive multiple lentigo-maligna-like lesions in a patient undergoing chemotherapy with an oral 5-fluorouracil prodrug for metastasizing colorectal carcinoma: a lesson for the pathogenesis of malignant melanoma?
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma; Colorectal Neoplasms; Deoxycytidine; Drug Eruptions; Fluorouracil; Humans; Hutchinson's Melanotic Freckle; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Nevus, Pigmented; Prodrugs; Skin; Skin Neoplasms | 2002 |
Penetration of capecitabine and its metabolites into malignant and healthy tissue of patients with advanced breast cancer.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Electrophoresis, Capillary; Extracellular Space; Floxuridine; Fluorouracil; Humans; Prodrugs; Skin Neoplasms; Tissue Distribution | 2002 |
Toxic encephalopathy induced by capecitabine.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Capecitabine; Deoxycytidine; Epilepsy; Female; Fluorouracil; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neurotoxicity Syndromes; Skin Neoplasms | 2004 |
Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Deoxycytidine; Eyelid Neoplasms; Female; Fluorouracil; Humans; Interferon-alpha; Male; Skin Neoplasms; Treatment Outcome | 2005 |
[Therapeutic efficacy of capecitabine on advanced and recurrent breast cancer with special reference to time to progression].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Capecitabine; Deoxycytidine; Disease Progression; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Skin Neoplasms | 2006 |
Clinically occult cutaneous metastases.
Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Capecitabine; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Lobular; Carcinoma, Signet Ring Cell; Deoxycytidine; Estradiol; Facial Neoplasms; Female; Fluorouracil; Fulvestrant; Humans; Incidental Findings; Letrozole; Mastectomy, Radical; Megestrol Acetate; Melanoma; Neoplasms, Second Primary; Neoplastic Cells, Circulating; Nitriles; Selective Estrogen Receptor Modulators; Skin Neoplasms; Tamoxifen; Triazoles; Wound Healing | 2006 |
Cutaneous metastasis resembling acute dermatitis in patient with advanced gastric cancer.
Topics: Antineoplastic Agents; Capecitabine; Cisplatin; Deoxycytidine; Dermatitis; Diagnosis, Differential; Female; Fluorouracil; Humans; Middle Aged; Skin Neoplasms; Stomach Neoplasms; Treatment Outcome | 2007 |
[Evaluation of combination therapy of high-dose toremifene and oral chemotherapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Floxuridine; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Quality of Life; Skin Neoplasms; Tegafur; Toremifene | 2007 |